Antioxidant effects of immunomodulators in patients with recurrent pyelonephritis
Journal Title: УКРАЇНСЬКИЙ ЖУРНАЛ НЕФРОЛОГІЇ ТА ДІАЛІЗУ - Year 2018, Vol 2, Issue 58
Abstract
The purpose of our work was to investigate the effect of immunomodulatory medicines on the intensity of oxidative stress (OS), the cytokines level and the activity of renospecific enzymes in patients with recurrent pyelonephritis (rPN). Methods. A prospective, randomized, open-label study involved of 100 women aged 33.4 ± 8.8 year old. According to the sensitivity of the detected pathogens all patients received antibacterial therapy for two weeks. Along with the main course of antibiotic therapy, 25 patients were assigned Sodium nucleinate at a dose of 0.25 g 4 times per day during 14 days, 18 patients were prescribed Galavit intramuscularly 2 ml per dayfor 10 days, and 27patients were prescribed Proteflazid according to the manufacturer’s instructions. The comparison group consisted of 30 women with rPN who received antibiotic therapy exclusively.Women were screened before and after the treatment. The content of malondialdehyde (MDA), ceruloplasmin (CP), transferrin (TF) and sulfhydryl groups (SH-groups) were determined in the blood by colorimetric method. Oxidative stress index (OSI) was calculated. The concentration of interleukins (IL) -1f, -4, -8, -10, -17, tumor necrosis factor a (TNF-a), transforming growth factor f (TGF-f), monocytic chemoactive protein-1 (MCP-1) and interferon y (IFN-y) were analyzed in the blood of the women using an ELISA. To evaluate the functional state of the renal parenchyma the activity of tubular lysosome enzymes a total f-N-acetylhexosaminidase and f-galactosidase were determined in urine. Results. The use of Sodium nucleinate decreased of the OS activity by reducing MDA level (p <0.001) and increasing the concentration of CP (p < 0.03). The serum levels ofIL-4 (p = 0.007), lL-17 (p = 0.04), TGF-f (p = 0.02) and MCP-1 (p = 0.03) were decrease. The use of Galavit contributed to a statistically significant decrease in the concentration of TNF-a (p <0.001), IL-8(p <0.001), IFN-y (p = 0.001) and TGF-f (p <0.001). The administration of Proteflazid resulted in a decrease in the concentrations of IL-8 and IFN-y, with a decrease in OSI (p =0.04) compared to pre-treatment. All applied immunomodulators partially reduced the activity of renospecific enzymes markers of kidney damage. Conclusions. The use of immunomodulators in the complex therapy of patients with rPN contributes to the partial normalization of functional activity of immune system by the decreasing ofthe production ofcytokines as its mediators and the reducing ofthe OS intensity.
Authors and Affiliations
M. Kolesnyk, L. V. Korol, N. M. Stepanova, V. Driianska, L. Ya. Migal
Keywords
Related Articles
- EP ID EP353195
- DOI 10.31450/ukrjnd.2(58).2018.04
- Views 111
- Downloads 0
Апоптоз як механізм індукованого альбуміном пошкодження нирок при нефротичному синдромі у дітей
Раніше у дослідженнях in vivo було показано, що ефекти, викликані протеїнурією, відіграють вирішальну роль в пошкодженні нирок при хронічному захворюванні нирок (ХЗН). Однак ініціальний механізм незворотного пошкодження...
СУДИННИЙ ЕНДОТЕЛІАЛЬНИЙ ФАКТОР РОСТУ ТА HLA-ФЕНОТИП У ХВОРИХ НА ХРОНІЧНИЙ ГЛОМЕРУЛОНЕФРИТ
Цель работы – установить особенности сывороточных уровней VEGF у больных хроническим гломерулонефритом с нефротическим синдромом и ассоциативные связи с HLA для определения дополнительных предикторов течения заболевания....
Protocol of chemical and bacteriological safety control of water for hemodialysis / haemodiafiltration
Conducting hemodialysis/ haemodiafiltration requires the presence of specially prepared water, which is the main component of the dialysing solution. The source of dialysis water is drinking (tap) water which is submitte...
ФАРМАКО-ЕКОНОМІЧНІ ПЕРЕВАГИ КОРЕКЦІЇ АНЕМІЇ ТРИВАЛИМ АКТИВАТОРОМ РЕЦЕПТОРІВ ЕРИТРОПОЕТИНУ: ГЕМОДІАЛІЗ ПРОТИ ГЕМОДІАФІЛЬТРАЦІЇ
Анемія невід’ємна складова ХХН. Еритропоез стимулюючі лікарські засоби (ЕСЗ) та інші медикаменти, які використовують для її лікування складають значне навантаження на бюджет охорони здоров’я. Використання тривалого актив...
PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION
Anemia is an integral component of CKD. The prescribing of erythropoiesis stimulating agents (ESA) for the treatment of anemia constitutes a significant burden on health budgets. Using of continuous erythropoietin recept...